In recent years, quantitative real-time PCR tests have been extensively developed in clinical microbiology laboratories for routine diagnosis of infectious diseases, particularly bacterial diseases.
First results of the prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text ...
According to WHO, it can be difficult to clinically distinguish Ebola disease from other infectious diseases such as malaria, typhoid fever, shigellosis, meningitis and other viral haemorrhagic fevers ...
The 2026 epidemic of Ebola virus disease caused by Bundibugyo virus (species Orthoebolavirus bundibugyoense) in DR Congo and Uganda has been declared a public health emergency of international concern ...
The question quickly arose whether existing rapid antigen tests could detect newly emerging variants. Using clinical samples obtained from diagnostic labs throughout the U.S. from 2020 to 2023, the ...
Doctors sometimes use tests for respiratory syncytial virus (RSV) to make or confirm a diagnosis. Here’s a look at the different kinds. There are two main kinds of RSV tests: rapid (antigen) and ...
Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it developed a Research Use Only (RUO) molecular PCR test, via its ...
PCR tests represent a major advance in the rapid diagnosis of infectious diseases. The qPCR technology has allowed easier and more effective implantation of molecular diagnosis in the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results